122 related articles for article (PubMed ID: 11900622)
1. Serum prolactin and response to treatment among cocaine-dependent individuals.
Patkar AA; Hill KP; Sterling RC; Gottheil E; Berrettini WH; Weinstein SP
Addict Biol; 2002 Jan; 7(1):45-53. PubMed ID: 11900622
[TBL] [Abstract][Full Text] [Related]
2. Relationship of serum prolactin with severity of drug use and treatment outcome in cocaine dependence.
Patkar AA; Mannelli P; Certa KM; Peindl K; Murray H; Vergare MJ; Berrettini WH
Psychopharmacology (Berl); 2004 Oct; 176(1):74-81. PubMed ID: 15064918
[TBL] [Abstract][Full Text] [Related]
3. Relationship between platelet serotonin uptake sites and measures of impulsivity, aggression, and craving among African-American cocaine abusers.
Patkar AA; Gottheil E; Berrettini WH; Hill KP; Thornton CC; Weinstein SP
Am J Addict; 2003; 12(5):432-47. PubMed ID: 14660157
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic sensitivity and cocaine abuse: response to apomorphine.
Hollander E; Nunes E; DeCaria CM; Quitkin FM; Cooper T; Wager S; Klein DF
Psychiatry Res; 1990 Aug; 33(2):161-9. PubMed ID: 2243893
[TBL] [Abstract][Full Text] [Related]
5. Bromocriptine treatment for cocaine addiction: association with plasma prolactin levels.
Gorelick DA; Wilkins JN
Drug Alcohol Depend; 2006 Feb; 81(2):189-95. PubMed ID: 16051446
[TBL] [Abstract][Full Text] [Related]
6. DHEAS and POMS measures identify cocaine dependence treatment outcome.
Wilkins JN; Majewska MD; Van Gorp W; Li SH; Hinken C; Plotkin D; Setoda D
Psychoneuroendocrinology; 2005 Jan; 30(1):18-28. PubMed ID: 15358439
[TBL] [Abstract][Full Text] [Related]
7. Pre-treatment measures of impulsivity, aggression and sensation seeking are associated with treatment outcome for African-American cocaine-dependent patients.
Patkar AA; Murray HW; Mannelli P; Gottheil E; Weinstein SP; Vergare MJ
J Addict Dis; 2004; 23(2):109-22. PubMed ID: 15132346
[TBL] [Abstract][Full Text] [Related]
8. Relationship of the serotonin transporter with prolactin response to meta-chlorophenylpiperazine in cocaine dependence.
Patkar AA; Mannelli P; Peindl K; Hill KP; Wu LT; Lee T; Kuhn C
J Psychiatr Res; 2008 Oct; 42(14):1213-9. PubMed ID: 18321529
[TBL] [Abstract][Full Text] [Related]
9. Predicting treatment-outcome in cocaine dependence from admission urine drug screen and peripheral serotonergic measures.
Patkar AA; Thornton CC; Berrettini WH; Gottheil E; Weinstein SP; Hill KP
J Subst Abuse Treat; 2002 Jul; 23(1):33-40. PubMed ID: 12127466
[TBL] [Abstract][Full Text] [Related]
10. Cocaine craving as a predictor of treatment attrition and outcomes after residential treatment for cocaine dependence.
Rohsenow DJ; Martin RA; Eaton CA; Monti PM
J Stud Alcohol Drugs; 2007 Sep; 68(5):641-8. PubMed ID: 17690796
[TBL] [Abstract][Full Text] [Related]
11. Nicotine dependence and treatment outcome among African American cocaine-dependent patients.
Patkar AA; Vergare MJ; Thornton CC; Weinstein SP; Murray HW; Leone FT
Nicotine Tob Res; 2003 Jun; 5(3):411-8. PubMed ID: 12791537
[TBL] [Abstract][Full Text] [Related]
12. Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study.
Satel SL; Price LH; Palumbo JM; McDougle CJ; Krystal JH; Gawin F; Charney DS; Heninger GR; Kleber HD
Am J Psychiatry; 1991 Dec; 148(12):1712-6. PubMed ID: 1957935
[TBL] [Abstract][Full Text] [Related]
13. Heroin and cocaine craving and use during treatment: measurement validation and potential relationships.
Heinz AJ; Epstein DH; Schroeder JR; Singleton EG; Heishman SJ; Preston KL
J Subst Abuse Treat; 2006 Dec; 31(4):355-64. PubMed ID: 17084789
[TBL] [Abstract][Full Text] [Related]
14. Hyperprolactinemia during cocaine withdrawal.
Mendelson J; Teoh S; Lange U; Mello N; Weiss R; Skupny A
NIDA Res Monogr; 1988; 81():67-73. PubMed ID: 3136392
[TBL] [Abstract][Full Text] [Related]
15. Bromocriptine in cocaine withdrawal--does it work?
Teller DW; Devenyi P
Int J Addict; 1988 Nov; 23(11):1197-205. PubMed ID: 3069753
[TBL] [Abstract][Full Text] [Related]
16. Effects of cocaine on basal and pulsatile prolactin levels in rhesus monkeys.
Honoré GM; King TS; Samuels MH; Moreno A; Siler-Khodr TM; Eddy CA; Schenken RS
J Soc Gynecol Investig; 2001; 8(6):351-7. PubMed ID: 11750871
[TBL] [Abstract][Full Text] [Related]
17. Effects of cortisol and cocaine on plasma prolactin and growth hormone levels in cocaine-dependent volunteers.
Elman I; Lukas SE
Addict Behav; 2005 May; 30(4):859-64. PubMed ID: 15833589
[TBL] [Abstract][Full Text] [Related]
18. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
Kreek MJ; Schluger J; Borg L; Gunduz M; Ho A
J Pharmacol Exp Ther; 1999 Jan; 288(1):260-9. PubMed ID: 9862779
[TBL] [Abstract][Full Text] [Related]
19. Difficulties in emotion regulation and impulse control during cocaine abstinence.
Fox HC; Axelrod SR; Paliwal P; Sleeper J; Sinha R
Drug Alcohol Depend; 2007 Jul; 89(2-3):298-301. PubMed ID: 17276626
[TBL] [Abstract][Full Text] [Related]
20. Effect of neuroleptic withdrawal on plasma prolactin: a possible marker of receptor adaptation.
Kirkpatrick B; Buchanan RW; Maeda K; Carpenter WT; Jauch D; Tamminga CA
Biol Psychiatry; 1989 Jun; 26(2):131-8. PubMed ID: 2567610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
